Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach

Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach

Background: The SARS-CoV-2 pandemic, caused by the novel coronavirus, has posed a significant global health threat since its emergence in late 2019. The World Health Organization declared the outbreak a pandemic on March 11, 2020, due to its rapid global spread and impact on public health. New varia...

Full description

Bibliographic Details
Main Authors:	Muhammad Zaheer, Nouman Ali, Hasnain Javed, Rimsha Munir, Nazia Jamil
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Journal of Infection and Public Health
Subjects:	Spike protein wild Spike protein Mutant ACE2 NRP1 GISAID MD Docking
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034123002460

Similar Items

Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2
by: Israa Mohamed Shamkh, et al.
Published: (2021-06-01)

Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants
by: Kwang-Eun Choi, et al.
Published: (2022-04-01)

Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2
by: Kwang-Eun Choi, et al.
Published: (2021-08-01)

In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19
by: Mahmoud Elkazzaz, et al.
Published: (2022-09-01)

<i>In silico</i> screening of chalcones and their derivatives as potential inhibitors of spike proteins and ACE2 enzymes for SARS-CoV-2 treatment
by: Thi Thu Hang Ta, et al.
Published: (2022-06-01)

Multifaceted membrane binding head of the SARS-CoV-2 spike protein
by: Anh Tran, et al.
Published: (2022-01-01)

Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022-12-01)

A novel inhibitor of SARS-CoV infection: Lactulose octasulfate interferes with ACE2-Spike protein binding
by: Rami Adel Pashameah, et al.
Published: (2024-01-01)

Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study
by: Taufik Muhammad Fakih, et al.
Published: (2021-12-01)

Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases
by: Kamal Shokeen, et al.
Published: (2022-09-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
by: Marcus Ho-Hin Shum, et al.
Published: (2024-12-01)

SARS-CoV-2 Spike Protein Activates Human Lung Macrophages
by: Francesco Palestra, et al.
Published: (2023-02-01)

The Utilization of Nutraceuticals and Phytochemical Compounds to Inhibit The Interaction of Spike-protein SARS-CoV-2 Virus and ACE-2 Receptor for COVID-19 Therapy (Literature Review)
by: David Ferdinand, et al.
Published: (2023-06-01)

Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33
by: Irene Tsilioni, et al.
Published: (2023-05-01)

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
by: Siu-Ying Lau, et al.
Published: (2020-01-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
by: Abdullah Hoter, et al.
Published: (2022-05-01)

Variable number tandem repeats of a 9-base insertion in the N-terminal domain of severe acute respiratory syndrome coronavirus 2 spike gene
by: Tetsuya Akaishi, et al.
Published: (2023-01-01)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
by: Gaofeng Pei, et al.
Published: (2022-07-01)

SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
by: Luís Queirós-Reis, et al.
Published: (2021-10-01)

A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance
by: Daniele Focosi
Published: (2023-04-01)

In-silico natural product database mining for novel neuropilin-1 inhibitors: molecular docking, molecular dynamics and binding energy computations
by: Mahmoud A. A. Ibrahim, et al.
Published: (2023-12-01)

Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays
by: Fulvio Perrella, et al.
Published: (2021-07-01)

Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
by: Wesam S. Ahmed, et al.
Published: (2022-07-01)

Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex
by: Wesam S. Ahmed, et al.
Published: (2022-10-01)

Missense mutations in spike protein of SARS‐CoV‐2 delta variant contribute to the alteration in viral structure and interaction with hACE2 receptor
by: Tousif Bin Mahmood, et al.
Published: (2022-09-01)

Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
by: Ai Fujimoto, et al.
Published: (2021-11-01)

Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages
by: Mukul Jain, et al.
Published: (2022-10-01)

Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein
by: Marc Sevenich, et al.
Published: (2022-02-01)

Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
by: Ivy Widjaja, et al.
Published: (2019-01-01)

Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity
by: Muhammad Hanifa, et al.
Published: (2023-01-01)

Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
by: Gábor Kemenesi, et al.
Published: (2021-01-01)

Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
by: Mehrnoosh Moghaddar, et al.
Published: (2021-10-01)

Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies
by: Nathalie Bonatti Franco Almeida, et al.
Published: (2023-10-01)

Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid
by: Yuichiro Yamamoto, et al.
Published: (2022-12-01)

A Comprehensive Review of COVID-19 Pathogenesis, Diagnosis, and Management
by: Zain Abbas, et al.
Published: (2023-06-01)

Structural analysis of SARS-CoV-2 genome and predictions of the human interactome
by: Vandelli, Andrea, et al.
Published: (2021)

A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants
by: Ludovico Pipitò, et al.
Published: (2022-10-01)

A cell-based, SARS-CoV-2 spike protein interaction assay to inform the neutralising capacity of recombinant and patient sera antibodies
by: Neale Harrison, et al.
Published: (2023-08-01)

Omicron Coronavirus: pH-Dependent Electrostatic Potential and Energy of Association of Spike Protein to ACE2 Receptor
by: Svetlana H. Hristova, et al.
Published: (2023-08-01)

A New Neutralization Epitope in the Spike Protein of Porcine Epidemic Diarrhea Virus
by: Jianbo Liu, et al.
Published: (2022-08-01)